| 阿立哌唑与氟哌啶醇治疗儿童、青少年精神分裂症的对照研究 |
| |
| 引用本文： | 李庆方,赵来田,王卫民,胡风领. 阿立哌唑与氟哌啶醇治疗儿童、青少年精神分裂症的对照研究[J]. 四川精神卫生, 2011, 24(1): 12-14 |
| |
| 作者姓名： | 李庆方 赵来田 王卫民 胡风领 |
| |
| 作者单位： | 安徽省铜陵市第三人民医院,244000 |
| |
| 摘 要： | 目的 探讨阿立哌唑治疗儿童、青少年精神分裂症的疗效及安全性.方法 将67例儿童、青少年精神分裂症患者随机分为阿立哌唑组(35例)和氟哌啶醇组(32例)进行对照研究,疗程8周.分别采用PANSS、BPRS、TESS及RSESE进行评定.结果 两组治疗后的PANSS、BPRS评分均较治疗前显著降低(P＜0.01),阿立哌唑...
|
| 关 键 词： | 阿立哌唑 氟哌啶醇 儿童、青少年精神分裂症 |
A controlled study of aripiprazole and haloperidol in the treatment of childhood or adolescent with schizophrenia |
| |
| LI Qingfang,ZHAO Laitian,WANG Weimin,et al.. A controlled study of aripiprazole and haloperidol in the treatment of childhood or adolescent with schizophrenia[J]. Sichuan Mental Health, 2011, 24(1): 12-14 |
| |
| Authors: | LI Qingfang ZHAO Laitian WANG Weimin et al. |
| |
| Affiliation: | LI Qingfang,ZHAO Laitian,WANG Weimin,et al.The Third People's Hospital of Tongling,Anhui 244000,China |
| |
| Abstract: | Objective To explore the efficacy and safety of aripiprazole in the treatment of childhood or adolescent with schizophrenia.Methods Patients who met CCMD-3 criteria for schizophrenia were randomized into two groups:aripiprazole group(n=35)and haloperidol group(n=32)in control study.The treatment duration was 8 weeks.The PANSS and BRPS were employed for assessing the treatment effectiveness.The TESS and RSESE were employed for assessing the side effects.Results The score of PANSS and BPRS of both groups sign... |
| |
| Keywords: | Aripiprazole Haloperidol Childhood or adolescent with schizophrenia |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
